Nemolizumab-Ilto Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 30 mg/mL
Reference Brands: Nemluvio (USA)
Category: Derma Drugs
Nemolizumab-ilto is available in Injection and strengths such as 30 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Nemolizumab-ilto is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Nemolizumab-ilto can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Nemolizumab-ilto injection is a biologic medicine used for the treatment of moderate to severe inflammatory skin conditions. It is administered alone or in combination with other treatments such as topical corticosteroids or calcineurin inhibitors when symptoms are not adequately controlled with topical therapy alone. This targeted treatment option is especially beneficial for patients who continue to experience persistent symptoms despite standard topical management.
Nemolizumab-ilto is also indicated for the treatment of prurigo nodularis, a chronic skin disorder characterized by intense itching and nodular skin lesions. By targeting specific immune pathways involved in itch and inflammation, nemolizumab-ilto helps reduce pruritus and improve skin condition. Its mechanism of action addresses the underlying causes of itch and inflammation rather than only providing symptomatic relief.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Nemolizumab-ilto is used for the treatment of prurigo nodularis in adults.
Nemolizumab-ilto is a recombinant humanized monoclonal antibody produced using biotechnology and genetic engineering techniques.
The trade name of nemolizumab-ilto is Nemluvio.
Nemluvio is developed and marketed by Galderma.
The generic name is nemolizumab-ilto.
The brand name is Nemluvio.
Nemolizumab-ilto is manufactured in specialized biologics manufacturing facilities, primarily in the United States and Europe, depending on the supply region.
Related Products
Acitretin
Strength:
10 mg, 17.5 mg, 22.5 mg, 25 mg
Form: Capsules
Reference Brands: Soriatane (USA), Neotigason (EU)
View Details
Mafenide
Strength:
10% w/w
Form: Creams
Reference Brands: Sulfamylon(USA), Flamazine (EU)
View Details
Aminolevulinic Acid
Strength:
78 mg/g
Form: Gel
Reference Brands: Levulan Kerastick (USA), Ameluz(USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
